# A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have N

Source: https://onco.cc/trials/nct07255404/  
OnCo record `nct07255404` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of PM8002, Paclitaxel / nab-paclitaxel, Gemcitabine in pancreatic ductal adenocarcinoma, run by BioNTech SE, now recruiting.

## Summary

A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer is a phase 2 interventional study registered as NCT07255404 by BioNTech SE, with 105 participants planned, started 2025-12-04 and due to reach its primary completion in 2027-12. Interventions recorded: Pumitamig, Nab-paclitaxel, Gemcitabine, mFOLFIRINOX. Conditions listed: Pancreatic Ductal Adenocarcinoma (PDAC). No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT07255404
- Phase: 2
- Setting: A Phase II, Multi-site, Randomized, Open-label, Trial of Pumitamig in Combination With Chemotherapy in Patients With Metastatic Pancreatic Cancer
- Sponsor: BioNTech SE
- Enrolled: 105

## Sources

- ClinicalTrials.gov NCT07255404: https://clinicaltrials.gov/study/NCT07255404

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- drugs: [FOLFIRINOX / mFOLFIRINOX](https://onco.cc/drugs/folfirinox/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/), [PM8002](https://onco.cc/drugs/pm8002/)
- companies: [BioNTech](https://onco.cc/companies/biontech/)

---
JSON: https://onco.cc/api/v1/entities/nct07255404.json